KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer

被引：0

作者：

Shitara, K. ^{[1
]}

Ozguroglu, M. ^{[2
]}

Bang, Y. J. ^{[3
]}

Di Bartolomeo, M. ^{[4
]}

Mandala, M. ^{[5
]}

Ryu, M. H. ^{[6
]}

Fornaro, L. ^{[7
]}

Olesinski, T. ^{[8
]}

Caglevic, C. ^{[9
]}

Chung, H. ^{[10
]}

Muro, K. ^{[11
]}

Gokkurt, E. ^{[12
]}

Mansoor, W. ^{[13
]}

McDermott, R. ^{[14
]}

Schacham-Shmueli, E. ^{[15
]}

Chen, X. ^{[16
]}

Kang, S. P. ^{[16
]}

Mayo, C. ^{[16
]}

Ohtsu, A. ^{[1
]}

Fuchs, C. ^{[17
]}

机构：

[1] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[2] Istanbul Univ, Cerrahpasa Sch Med, Istanbul, Turkey

[3] Seoul Natl Univ, Coll Med, Seoul, South Korea

[4] Fdn IRCCS Ist Nazl Tumori, Milan, Italy

[5] Papa Giovanni XXIII Hosp, Bergamo, Italy

[6] Asan Med Ctr, Seoul, South Korea

[7] Azienda Osped Univ Pisana, Pisa, Italy

[8] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland

[9] Inst Oncol Fdn Arturo Lopez Perez, Santiago, Chile

[10] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Seoul, South Korea

[11] Aichi Canc Ctr Hosp, Nagoya, Aichi, Japan

[12] HOPE, Hamburg, Germany

[13] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England

[14] Adelaide & Meath Hosp, Dublin, Ireland

[15] Sheba Med Ctr, Ramat Gan, Israel

[16] Merck & Co Inc, Kenilworth, NJ USA

[17] Yale Canc Ctr, New Haven, CT USA

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA - 005

引用

页数：1

共 50 条

[21] Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer Phase 2 Clinical KEYNOTE-059 Trial
Fuchs, Charles S.
Doi, Toshihiko
Jang, Raymond W.
Muro, Kei
Satoh, Taroh
Machado, Manuela
Sun, Weijing
Jalal, Shadia I.
Shah, Manish A.
Metges, Jean-Phillipe
Garrido, Marcelo
Golan, Talia
Mandala, Mario
Wainberg, Zev A.
Catenacci, Daniel V.
Ohtsu, Atsushi
Shitara, Kohei
Geva, Ravit
Bleeker, Jonathan
Ko, Andrew H.
Ku, Geoffrey
Philip, Philip
Enzinger, Peter C.
Bang, Yung-Jue
Levitan, Diane
Wang, Jiangdian
Rosales, Minori
Dalal, Rita P.
Yoon, Harry H.
JAMA ONCOLOGY, 2018, 4 (05)
[22] Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials
Chao, Joseph
Fuchs, Charles S.
Shitara, Kohei
Tabernero, Josep
Muro, Kei
Van Cutsem, Eric
Bang, Yung-Jue
De Vita, Ferdinando
Landers, Gregory
Yen, Chia-Jui
Chau, Ian
Elme, Anneli
Lee, Jeeyun
Ozguroglu, Mustafa
Catenacci, Daniel
Yoon, Harry H.
Chen, Erluo
Adelberg, David
Shih, Chie-Schin
Shah, Sukrut
Bhagia, Pooja
Wainberg, Zev A.
JAMA ONCOLOGY, 2021, 7 (06) : 895 - 902
[23] A phase 3 study of chemotherapy 1 pembrolizumab vs chemotherapy 1 placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer: KEYNOTE-585-Trial in progress
Bang, Y.
Van Cutsem, E.
Fuchs, C.
Ohtsu, A.
Tabernero, J.
Ilson, D.
Hyung, W.
Strong, V.
Goetze, T.
Yoshikawa, T.
Tang, L.
Hwang, P.
Shitara, K.
ANNALS OF ONCOLOGY, 2018, 29
[24] Ramucirumab (R) plus pembrolizumab (P) in treatment naive and previously treated advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: A multi-disease phase I study.
Chau, Ian
Bendell, Johanna C.
Calvo, Emiliano
-Davila, Rafael Santana
Arkenau, Hendrik-Tobias
Mi, Gu
Jin, Jin
Rege, Jessicca
Ferry, David
Herbst, Roy S.
Fuchs, Charles S.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[25] Pembrolizumab plus chemotherapy for previously untreated, HER2-negative unresectable or metastatic advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: KEYNOTE-859.
Tabernero, Josep
Bang, Yung-Jue
Van Cutsem, Eric
Fuchs, Charles S.
Janjigian, Yelena Y.
Bhagia, Pooja
Li Kan
Adelberg, David E.
Kui, Qin Shu
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
[26] Association between gene expression signatures and outcomes of pembrolizumab (pembro) and paclitaxel (pac) in advanced gastric cancer (GC): Exploratory analysis from KEYNOTE-061
Shitara, Kohei
Di Bartolomeo, Maria
Mandala, Mario
Ryu, Min-Hee
Caglevic, Christian
Olesinski, Tomasz
Chung, Hyun C.
Muro, Kei
Goekkurt, Eray
McDermott, Raymond S.
Mansoor, Wasat
Wainberg, Zev A.
Shih, Chie-Schin
Kobie, Julie
Nebozhyn, Michael
Cristescu, Razvan
Cao, Z. Alexander
Loboda, Andrey
Ozguroglu, Mustafa
CANCER RESEARCH, 2022, 82 (12)
[27] Safety and efficacy of ramucirumab (R) plus pembrolizumab (P) in treatment naive and previously treated advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: a multi-disease phase 1 study
Thuss-Patience, P.
Vasile, E.
Chau, I
Penel, N.
Mi, G.
Emig, M.
Fuchs, C. S.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 254 - 255
[28] KEYNOTE-585: Phase 3 study of chemotherapy (chemo) plus pembrolizumab (pembro) vs chemo plus placebo as neoadjuvant/adjuvant treatment for patients (pts) with gastric or gastroesophageal junction (G/GEJ) cancer.
Bang, Yung-Jue
Van Cutsem, Eric
Fuchs, Charles S.
Ohtsu, Atsushi
Tabernero, Josep
Ilson, David H.
Hyung, Woo Jin
Strong, Vivian E.
Goetze, Thorsten Oliver
Yoshikawa, Takaki
Tang, Laura H.
Hwang, Peggy May Tan
Shitara, Kohei
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[29] KEYNOTE-059 cohort 1: Pembrolizumab (Pembro) monotherapy in previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer in patients (Pts) with PD-L1+tumors-Asian subgroup analysis.
Muro, Kei
Fuchs, Charles S.
Jang, Raymond Woo-Jun
Satoh, Taroh
Machado, Manuela
Sun, Weijing
Jalal, Shadia Ibrahim
Shah, Manish A.
Metges, Jean-Philippe
Garrido, Marcelo
Golan, Talia
Mandala, Mario
Wainberg, Zev A.
Catenacci, Daniel V. T.
Bang, Yung-Jue
Lin, Jianxin
Lu, Jia
Yoon, Harry H.
Doi, Toshihiko
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
[30] Pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (G/GEJ) cancer: Initial findings of the global phase 3 KEYNOTE-811 study.
Janjigian, Yelena Y.
Kawazoe, Akihito
Yanez, Patricio Eduardo
Luo, Suxia
Lonardi, Sara
Kolesnik, Oleksii
Barajas, Olga
Bai, Yuxian
Shen, Lin
Tang, Yong
Wyrwicz, Lucjan
Shitara, Kohei
Qin, Shukui
Van Cutsem, Eric
Tabernero, Josep
Li, Lie
Shih, Chie-Schin
Bhagia, Pooja
Chung, Hyun Cheol Cheol
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 3 4 5 →